- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 7/00 - Drugs for disorders of the blood or the extracellular fluid
Patent holdings for IPC class A61P 7/00
Total number of patents in this class: 2634
10-year publication summary
|
91
|
89
|
97
|
180
|
172
|
207
|
241
|
190
|
237
|
76
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11238 |
38 |
| Alexion Pharmaceuticals, Inc. | 606 |
36 |
| Takeda Pharmaceutical Company Limited | 2961 |
33 |
| Global Blood Therapeutics, Inc. | 180 |
30 |
| The Regents of the University of California | 18943 |
23 |
| Acceleron Pharma Inc. | 365 |
23 |
| Jiangsu Hengrui Medicine Co., Ltd. | 780 |
19 |
| Bayer Pharma AG | 1096 |
18 |
| Bristol-myers Squibb Company | 5080 |
16 |
| President and Fellows of Harvard College | 5792 |
16 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 588 |
16 |
| F. Hoffmann-La Roche AG | 7958 |
15 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
15 |
| Daiichi Sankyo Company, Limited | 1829 |
15 |
| The University of Tokyo | 3903 |
15 |
| Nippon Shinyaku Co., Ltd. | 297 |
14 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
14 |
| Vertex Pharmaceuticals Incorporated | 1581 |
12 |
| Nissan Chemical Industries, Ltd. | 1822 |
12 |
| Sichuan Inlu Weite Pharmaceutical Technology Co., Ltd. | 20 |
12 |
| Other owners | 2242 |